Therapeutics involved in managing initial and recurrent Clostridium difficile infection: An updated literature review

doi:10.4292/wjgpt.v15.i5.95467

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (69)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-1)

Sum=56

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=7

Publishing Process of This Article

Item

Count

Browse

Download

Sum=5

Sep 5, 2024 (publication date) through Sep 4, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Pharmacol Ther. Sep 5, 2024; 15(5): 95467
Published online Sep 5, 2024. doi: 10.4292/wjgpt.v15.i5.95467

Open in New Tab Full Size Figure Download Figure

Figure 1 Production of toxins A and B and the colonization of Clostridium difficile causing disruption of the epithelial barrier and an inflammatory response leading to neutrophil recruitment and the development of a pseudomembrane. C. difficile: Clostridium difficile.

Citation: Nagesh VK, Tran HHV, Elias D, Kianifar Aguilar I, Sethi T, Menon A, Mansour C, Furman F, Tsotsos K, Subar T, Auda A, Sidiqui A, Lamar J, Wadhwani N, Dey S, Lo A, Atoot A, Weissman S, Sifuentes H, Bangolo AI. Therapeutics involved in managing initial and recurrent Clostridium difficile infection: An updated literature review. World J Gastrointest Pharmacol Ther 2024; 15(5): 95467
URL: https://www.wjgnet.com/2150-5349/full/v15/i5/95467.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v15.i5.95467